4//SEC Filing
Weiss Amir 4
Accession 0000950170-24-061334
CIK 0000818686other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 7:41 AM ET
Size
7.1 KB
Accession
0000950170-24-061334
Insider Transaction Report
Form 4
Weiss Amir
Chief Accounting Officer
Transactions
- Sale
Ordinary Shares
2024-05-15$16.80/sh−15,500$260,417→ 17,814 total - Sale
Ordinary Shares
2024-05-16$16.65/sh−12,635$210,377→ 5,179 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.800 to $16.805, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.65 to $16.655, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001897057
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 7:41 AM ET
- Size
- 7.1 KB